lymphoma

U.S. regulators in July of 2016 halted a trial of Juno Therapeutics Inc.’s experimental cancer therapy, known as JCAR015, after three patients died.
JCAR015 uses genetically engineered cells as a treatment for cancer. However, one of the pursuits in oncology was temporarily halted by the FDA when some of the participants developed fatal swelling in the brain.
Hans Bishop, Juno’s chief executive, said in a conference call with securities analysts that the deaths were “difficult and humbling for everyone involved.”

Three key scientific studies that would reveal possible risks to human and environmental health from the use of the herbicide chemical glyphosate have been held back in the name of ‘trade secret protection.”

Thanks to the admitted link between Monsanto’s best-selling herbicide known as Roundup and the development of cancer, another major lawsuit could be coming up against the biotech titan. This would be the second major lawsuit over Monsanto’s Roundup health risk, following awareness campaigns launched by groups like March Against Monsanto and individuals like Anthony Gucciardi.